Effectiveness and Safety of Intrathecal Ziconotide: Final Results of the Patient Registry of Intrathecal Ziconotide Management (PRIZM).

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

The Patient Registry of Intrathecal Ziconotide Management evaluated the long-term effectiveness and safety of intrathecal ziconotide.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Pain Med

Title: Pain medicine (Malden, Mass.)

Publisher: Oxford University Press (OUP)

ISSN (Electronic): 1526-4637

ISSN (Print): 1526-2375

Publication date (Electronic): November 01 2020

Volume: 21

Issue: 11

Affiliations

[1 ] Integrated Pain Solutions, Columbus, Ohio.

[2 ] MossRehab, Elkins Park, Pennsylvania.

[3 ] University of California, San Diego, La Jolla, California.

[4 ] Neurovations Clinical Research, Napa, California.

[5 ] Carolinas Pain Institute, The Center for Clinical Research, Winston-Salem, North Carolina.

[6 ] Center for Interventional Pain and Spine, LLC, Newark, Delaware.

[7 ] ‖|Surrozen Inc, South San Francisco, California; **Jazz Pharmaceuticals, Palo Alto, California; ††Grail Inc, Menlo Park, California.

[8 ] The Spine and Nerve Center of the Virginias, Charleston, West Virginia, USA.

Article

Publisher Item ID: 5848741

DOI: 10.1093/pm/pnaa115

PubMed ID: 32472137

SO-VID: e2be2f43-cd4d-4882-8123-8076e680703d

Copyright © © The Author(s) 2020. Published by Oxford University Press on behalf of the American Academy of Pain Medicine. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

History

Keywords: Chronic Pain,Intrathecal,Nonopioid,Registry,Ziconotide

Data availability:

Keywords: Chronic Pain, Intrathecal, Nonopioid, Registry, Ziconotide

Comments

Comment on this article

scite_

Cited by 3

See all cited by